The precise incidence of low-grade gliomas is a shifting target since adopting 2016 WHO CNS classification among tumor registries is just beginning. Based on the studies using the previous classification, the incidence of grade 2 oligodendrogliomas is 0.25, for astrocytomas is 0.51, and for mixed gliomaÂ is 0.20 per 100000 per year in the United States.